Georges Deschênes
机构:Inserm, University of Zurich, Assistance Publique – Hôpitaux de Paris, Collaborative Group (United States), Hôpital Robert-Debré, Institut des Maladies Génétiques Imagine · ORCID:0000-0002-5158-2915
发表论文 386 篇 · 总被引 14180 次 · h-index 66
代表论文
- Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 (2021 · New England Journal of Medicine · 被引 512)
- Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1 (2021 · Clinical Journal of the American Society of Nephrology · 被引 81)
- Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children (2021 · Genetics in Medicine · 被引 74)
- An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis (2021 · Kidney International · 被引 72)
- Obinutuzumab in Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome in Children (2023 · Clinical Journal of the American Society of Nephrology · 被引 64)
- The genetic landscape and clinical spectrum of nephronophthisis and related ciliopathies (2023 · Kidney International · 被引 53)